Literature DB >> 8349763

Bacteroides fragilis strains express multiple capsular polysaccharides.

A Pantosti1, A O Tzianabos, B G Reinap, A B Onderdonk, D L Kasper.   

Abstract

Previous studies by our group have demonstrated that the capsule of Bacteroides fragilis type strain NCTC 9343 consists of two chemically distinct polysaccharides, designated PS A and PS B. These polysaccharides can be isolated as an aggregate from the surface of the organism and give a complex multiprecipitin profile when they are reacted with homologous antiserum in an immunoelectrophoresis assay. Following structural analysis of PS A and PS B, we have determined that the complex precipitin profile is formed as a result of the differing electrophoretic and antigenic properties associated with each of these polymers. Presently, we have examined the capsular polysaccharides of 13 other strains of B. fragilis according to methods used for the prototype strain. The capsules of these strains were extracted, partially purified, and analyzed by immunoelectrophoresis at pH 7.3. Following reaction with homologous polyclonal antisera, each of the capsular preparations tested yielded a complex precipitin profile similar to that of the prototype strain. When reacted by immunoelectrophoresis with polyclonal antiserum to 9343 or with monoclonal antibodies to PS A and PS B, these capsular preparations appeared to be antigenically diverse; some preparations (50%) showed complete or partial cross-reaction. These results suggest that the dual polysaccharide motif seen with the prototype strain is a common feature of B. fragilis strains. In addition, the antigenic heterogeneity of B. fragilis capsular polysaccharides could be used for the development of a serological typing scheme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349763      PMCID: PMC265644          DOI: 10.1128/jcm.31.7.1850-1855.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.

Authors:  A B Onderdonk; D L Kasper; R L Cisneros; J G Bartlett
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

2.  The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.

Authors:  D L Kasper
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

3.  HL-A-W27--a useful discriminator in the arthropathies of inflammatory bowel disease.

Authors:  R I Morris; A L Metzger; R Bluestone; P I Terasaki
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

4.  ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes.

Authors:  B M Gray
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

5.  Serogrouping of Bacteroides fragilis subsp. fragilis by the agglutination test.

Authors:  D W Lambe; D A Moroz
Journal:  J Clin Microbiol       Date:  1976-06       Impact factor: 5.948

6.  Immunochemical characterization of the outer membrane complex of Bacteroides fragilis subspecies fragilis.

Authors:  D L Kasper; M W Seiler
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

7.  Encapsulated strains of Bacteroides fragilis in clinical specimens.

Authors:  A A Lindberg; P Berthold; C E Nord; A Weintraub
Journal:  Med Microbiol Immunol       Date:  1979-03-13       Impact factor: 3.402

8.  The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides.

Authors:  A O Tzianabos; A Pantosti; H Baumann; J R Brisson; H J Jennings; D L Kasper
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

9.  Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.

Authors:  D L Kasper; A B Onderdonk; J Crabb; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

10.  Serological studies of Bacteroides fragilis.

Authors:  K M Elhag; K A Bettelheim; S Tabaqchali
Journal:  J Hyg (Lond)       Date:  1977-10
View more
  13 in total

1.  The gut microbiome in multiple sclerosis.

Authors:  Daniel W Mielcarz; Lloyd H Kasper
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

2.  Interstrain variation of the polysaccharide B biosynthesis locus of Bacteroides fragilis: characterization of the region from strain 638R.

Authors:  L E Comstock; M J Coyne; A O Tzianabos; D L Kasper
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

3.  Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain.

Authors:  W M Kalka-Moll; Y Wang; L E Comstock; S E Gonzalez; A O Tzianabos; D L Kasper
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.

Authors:  A O Tzianabos; D L Kasper; R L Cisneros; R S Smith; A B Onderdonk
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

5.  Diversity of the metalloprotease toxin produced by enterotoxigenic Bacteroides fragilis.

Authors:  Shaoguang Wu; Lawrence A Dreyfus; Art O Tzianabos; Chika Hayashi; Cynthia L Sears
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice.

Authors:  Ki-Jong Rhee; Shaoguang Wu; Xinqun Wu; David L Huso; Baktiar Karim; Augusto A Franco; Shervin Rabizadeh; Jonathan E Golub; Lauren E Mathews; Jai Shin; R Balfour Sartor; Douglas Golenbock; Abdel R Hamad; Christine M Gan; Franck Housseau; Cynthia L Sears
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

7.  Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.

Authors:  A O Tzianabos; A B Onderdonk; D F Zaleznik; R S Smith; D L Kasper
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Resistance of a Tn4351-generated polysaccharide mutant of Porphyromonas gingivalis to polymorphonuclear leukocyte killing.

Authors:  C A Genco; R E Schifferle; T Njoroge; R Y Forng; C W Cutler
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.

Authors:  A Pantosti; R Colangeli; A O Tzianabos; D L Kasper
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

10.  Tumor necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species.

Authors:  D M Delahooke; G R Barclay; I R Poxton
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.